Plasma osteopontin modulates chronic restraint stress-induced thymus atrophy by regulating stress hormones: Inhibition by an anti-osteopontin monoclonal antibody

Journal of Immunology

Volumn 182, Issue 4, 2009, Pages 2485-2491

  Wang, Kathryn X ^a   Shi, Yufang F ^c   Ron, Yacov ^c   Kazanecki, Christian C ^a   Denhardt, David T ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b State University of New Jersey   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CORTICOSTERONE; MONOCLONAL ANTIBODY; OSTEOPONTIN; STRESS HORMONE; CORTICOTROPIN;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL STRESS; CONTROLLED STUDY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MECHANICAL STRESS; MENTAL STRESS; MOUSE; NONHUMAN; OXIDATIVE STRESS; PHYSICAL STRESS; PRIORITY JOURNAL; STEROIDOGENESIS; THYMUS ATROPHY; ANIMAL; ATROPHY; BLOOD; DRUG ANTAGONISM; EXERCISE; GENETICS; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IMMUNOLOGY; MOUSE MUTANT; PATHOLOGY; THYMUS;

ADRENOCORTICOTROPIC HORMONE; ANIMALS; ANTIBODIES, MONOCLONAL; ATROPHY; CORTICOSTERONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MICE; MICE, KNOCKOUT; OSTEOPONTIN; PITUITARY-ADRENAL SYSTEM; RESTRAINT, PHYSICAL; STRESS, PSYCHOLOGICAL; THYMUS GLAND;

EID: 61449249594     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803023     Document Type: Article

References (33)

1. Denhardt, D. T., M. Noda, A. W. O'Regan, D. Pavlin, and J. S. Berman. 2001. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J. Clin. Invest. 107: 1055-1061.
2. Sodek, J., A. P. Batista Da Silva, and R. Zohar. 2006. Osteopontin and mucosal protection. J. Dent. Res. 85: 404-415.
3. Scatena, M., L. Liaw, and C. M. Giachelli. 2007. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler. Thromb. Vasc. Biol. 27: 2302-2309.
4. Wang, K. X., and D. T. Denhardt. 2008. Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev. 19: 333-345.
5. Itoh, Y., T. Yasui, A. Okada, K. Tozawa, Y. Hayashi, and K. Kohri. 2005. Examination of the anti-oxidative effect in renal tubular cells and apoptosis by oxidative stress. Urol. Res. 33: 261-266.
6. Fujihara, S., M. Yokozeki, Y. Oba, Y. Higashibata, S. Nomura, and K. Moriyama. 2006. Function and regulation of osteopontin in response to mechanical stress. J. Bone Miner. Res. 21: 956-964.
7. Wai, P. Y., and P. C. Kuo. 2004. The role of osteopontin in tumor metastasis. J. Surg. Res. 121: 228-241.
8. Wang, K. X., Y. Shi, and D. T. Denhardt. 2007. Osteopontin regulates hind limb-unloading-induced lymphoid organ atrophy and weight loss by modulating corticosteroid production. Proc. Natl. Acad. Sci. USA 104: 14777-14782.
9. Sonnenfeld, G. 2005. The immune system in space, including earth-based benefits of space-based research. Curr. Pharmacol. Biotech. 6: 343-349.
10. Nacher, J., K. Pham, V. Gil-Fernandez, and B. S. McEwen. 2004. Chronic restraint stress and chronic corticosterone treatment modulate differentially the expression of molecules related to structural plasticity in the adult rat piriform cortex. Neuroscience 126: 503-509.
11. Yin, D., D. Tuthill, R. A. Mufson, and Y. Shi. 2000. Chronic restraint stress promotes lymphocyte apoptosis by modulating CD95 expression. J. Exp. Med. 191: 1423-1428.
12. Zhang, Y., M. Woodruff, Y. Zhang, J. Miao, G. Hanley, C. Stuart, X. Zeng, S. Prabhakar, J. Moorman, B. Zhao, and D. Yin. 2008. Toll-like receptor 4 mediates chronic restraint stress-induced immune suppression. J. Neuroimmunol. 194: 115-122.
13. Bowers, S. L., S. D. Bilbo, F. S. Dhabhar, and R. J. Nelson. 2008. Stressorspecific alterations in corticosterone and immune responses in mice. Brain Behav.Immun. 22: 105-113.
14. Rittling, S. R., H. N. Matsumoto, M. D. McKee, A. Nanci, X. R. An, K. E. Novick, A. J. Kowalski, M. Noda, and D. T. Denhardt. 1998. Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J. Bone Miner. Res. 13: 1101-1111.
15. Natasha, T., M. Kuhn, O. Kelly, and S. R. Rittling. 2006. Override of the osteoclast defect in osteopontin-deficient mice by metastatic tumor growth in the bone. Am. J. Pathol. 168: 551-561.
16. Shinohara, M. L., L. Lu, J. Bu, M. B. Werneck, K. S. Kobayashi, L. H. Glimcher, and H. Cantor. 2006. Osteopontin expression is essential for interferon-α production by plasmacytoid dendritic cells. Nat. Immunol. 7: 498-506.
17. Wu, Y., D. T. Denhardt, and S. R. Rittling. 2000. Osteopontin is required for full expression of the transformed phenotype by the ras oncogene. Br. J. Cancer 83: 156-163.
18. Kowalski, A. J. 2005. Creation, characterization, and application of novel antiosteopontin monoclonal antibodies. Doctoral dissertation, Rutgers, The State University of New Jersey, Piscataway, NJ.
19. Christensen, B., C. C. Kazanecki, T. E. Petersen, S. R. Rittling, D. T. Denhardt, and E. S. SØrensen. 2007. Cell type-specific post-translational modifications of mouse osteopontin are associated with different adhesive properties. J. Biol. Chem. 282: 19463-19472.
20. Wang, K. X. 2008. Osteopontin: role in immune regulation and stress responses. Doctoral dissertation, Rutgers, The State University of New Jersey, Piscataway, NJ.
21. Keller-Wood, M. E., and M. F. Dallman. 1984. Corticosteroid inhibition of ACTH secretion. Endocr. Rev. 5: 1-24.
22. Kazanecki, C. C., A. J. Kowalski, T. Ding, S. R. Rittling, and D. T. Denhardt. 2007. Characterization of anti-osteopontin monoclonal antibodies: binding sensitivity to post-translational modifications. J. Cell Biochem. 102: 925-935.
23. Zohar, R., B. Zhu, P. Liu, J. Sodek, and C. A. McCulloch. 2004. Increased cell death in osteopontin-deficient cardiac fibroblasts occurs by a caspase-3-independent pathway. Am. J. Physiol. 287: H1730-H1739.
24. Aviles, H., T. Belay, M. Vance, and G. Sonnenfeld. 2005. Effects of space flight conditions on the function of the immune system and catecholamine production simulated in a rodent model of hind limb unloading. Neuroimmunomodulation 12: 173-181.
25. Dhabhar, F. S., A. R. Satoskar, H. Bluethmann, J. R. David, and B. S. McEwen. 2000. Stress-induced enhancement of skin immune function: a role for γ interferon. Proc. Natl. Acad. Sci. USA 97: 2846-2851.
26. Offner, H., S. Subramanian, S. M. Parker, C. Wang, M. E. Afentoulis, A. Lewis, A. A. Vandenbark, and P. D. Hurn. 2006. Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J. Immunol. 176: 6523-6531.
27. Pearse, G. 2006. Histopathology of the thymus. Toxicol. Pathol. 34: 515-547.
28. Chen, C. C., and C. R. Parker, Jr. 2004. Adrenal androgens and the immune system. Semin. Reprod. Med. 22: 369-377.
29. Calcagni, E., and I. Elenkov. 2006. Stress system activity, innate and T helper cytokines, and susceptibility to immune-related diseases. Ann. NY Acad. Sci. 1069: 62-76.
30. Heesen, C., S. M. Gold, I. Huitinga, and J. M. Reul. 2007. Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis. Psychoneuroendocrinology 32: 604-618.
31. Harbuz, M. S., G. L. Conde, O. Marti, S. L. Lightman, and D. S. Jessop. 1997. The hypothalamic-pituitary-adrenal axis in autoimmunity. Ann. NY Acad. Sci. 823: 214-224.
32. Hur, E. M., S. Youssef, M. E. Haws, S. Y. Zhang, R. A. Sobel, and L. Steinman. 2007. Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nat. Immunol. 8: 74-83.
33. Cao, Z., J. Dai, K. Fan, H. Wang, G. Ji, B. Li, D. Zhang, S. Hou, W. Qian, J. Zhao, H. Wang, and Y. Guo. 2008. A novel functional motif of osteopontin for human lymphocyte migration and survival. Mol. Immunol. 45: 3683-3692.